StockMarketWire.com - Wound-care technology group Spectral MD posted a first-half loss as it continued to commercialise it products.

Pre-tax losses for the six months through June amounted to £0.88 million, compared to a year-on-year profit of £1.72 million. Revenue was broadly steady at £7.0 million.

'We have exceeded the commercial milestones we set for the company in our admission document,' chief executive Wensheng Fan said.


Story provided by StockMarketWire.com